Table 3 |
|||
|
Characteristics of highly-cited and infrequently-cited publications examining coronary artery disease prevention |
|||
| Characteristic |
Highly-Cited |
Infrequently-Cited |
P-Value |
|
|
|||
| Year (mean ± SD) |
2000.9 ± 2.0 |
2000.9 ± 2.1 |
0.66 |
| Journal Name (%) |
|||
| Circulation |
23.4 |
0.8 |
<0.0001 |
| Lancet |
6.8 |
0 |
|
| JAMA |
12.3 |
0 |
|
| Journal of the American College of Cardiology |
4.0 |
0 |
|
| New England Journal of Medicine |
7.9 |
0 |
|
| Other |
45.6 |
99.2 |
|
| Journal Type (%) |
|||
| Cardiovascular |
35.2 |
27.8 |
<0.0001 |
| Endocrinology/Metabolism |
3.9 |
5.6 |
|
| General Medicine |
43.4 |
20.6 |
|
| Health Services or Heath Policy |
0 |
7.1 |
|
| Nutrition/Diet |
4.7 |
4.0 |
|
| Pharmacology |
2.3 |
9.9 |
|
| Public, Environmental, or Occupational Health |
3.1 |
7.5 |
|
| Other |
7.4 |
17.5 |
|
| Journal Circulation (%) |
|||
| High |
36.1 |
6.0 |
<0.0001 |
| Medium |
42.1 |
7.5 |
|
| Low |
21.8 |
86.5 |
|
| Journal Impact Factor (%) |
|||
| High |
54.4 |
1.6 |
<0.0001 |
| Medium |
33.7 |
10.7 |
|
| Low |
11.9 |
87.7 |
|
| Topic (%) |
|||
| Medications |
44.5 |
42.5 |
0.04 |
| New Technologies |
4.0 |
3.6 |
|
| Risk Factors |
36.9 |
29.8 |
|
| Other |
14.7 |
24.2 |
|
| Country (%) |
|||
| United States |
61.5 |
32.9 |
<0.0001 |
| United Kingdom |
16.7 |
11.9 |
|
| Other |
21.8 |
55.2 |
|
|
|
|||
|
Abbreviations: SD = standard deviation, JAMA = Journal of the American Medical Association |
|||
|
Filion and Pless Epidemiologic Perspectives & Innovations 2008 5:3 doi:10.1186/1742-5573-5-3 |
|||
